Immunomodulation and Biomaterials: Key Players to Repair Volumetric Muscle Loss

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Immunology

Background:

• Volumetric muscle loss (VML) involves significant skeletal muscle loss, leading to functional impairment and a growing economic burden.
• Current treatments for VML are lacking, necessitating novel therapeutic strategies.
• The immune response, particularly involving macrophages, plays a critical role in muscle injury and regeneration.

Purpose of the Study:

• To review the role of immune cells and biomaterials in skeletal muscle regeneration following VML.
• To explore strategies for overcoming challenges in cell therapy delivery for VML.
• To highlight the potential of combining biomaterials with cell-based therapies for VML treatment.

Main Methods:

• Review of current literature on VML, immune responses, and biomaterial applications in muscle regeneration.
• Analysis of the interplay between immune cells (especially macrophages) and muscle tissue.
• Examination of various biomaterials designed for muscle injury repair.

Main Results:

• Biomaterials offer tunable properties for enhancing muscle regeneration and mitigating adverse immune responses.
• Cell therapy, when combined with appropriate biomaterials, shows promise for VML repair.
• Understanding immune cell function is crucial for developing effective regenerative strategies.

Conclusions:

• Biomaterials can be engineered to modulate the immune environment and promote skeletal muscle regeneration.
• The synergistic use of immune cells and advanced biomaterials presents a promising therapeutic avenue for VML.
• Further research into immune-biomaterial interactions is essential for effective VML treatment development.